FRANCODEX SANTE ANIMALE : revenue, balance sheet and financial ratios

FRANCODEX SANTE ANIMALE is a French company founded 16 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in SAINTES (17100), this company of category ETI shows in 2019 a revenue of 8.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - FRANCODEX SANTE ANIMALE (SIREN 513639054)
Indicator 2024 2023 2019 2018 2017 2016
Revenue N/C N/C 8 032 676 € 7 581 736 € 7 015 764 € 7 100 178 €
Net income 890 748 € 774 163 € 326 736 € 31 980 € 237 525 € 324 875 €
EBITDA N/C N/C 507 729 € 337 128 € 481 666 € 493 114 €
Net margin N/C N/C 4.1% 0.4% 3.4% 4.6%

Revenue and income statement

In 2024, FRANCODEX SANTE ANIMALE generates positive net income of 891 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 325 k€ -> 891 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

890 748 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 3%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 75%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

3.291%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

74.506%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

51.5%

Solvency indicators evolution
FRANCODEX SANTE ANIMALE

Sector positioning

Debt ratio
3.29 2024
2019
2023
2024
Q1: 0.0
Med: 4.27
Q3: 43.96
Good -23 pts over 3 years

In 2024, the debt ratio of FRANCODEX SANTE ANIMALE (3.29) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
74.51% 2024
2019
2023
2024
Q1: 14.64%
Med: 38.36%
Q3: 60.56%
Excellent +31 pts over 3 years

In 2024, the financial autonomy of FRANCODEX SANTE ANIMALE (74.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
2.44 years 2019
2019
Q1: 0.0 years
Med: 0.0 years
Q3: 1.29 years
Watch

In 2019, the repayment capacity of FRANCODEX SANTE ANIMALE (2.44) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 353.28. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

353.281

Liquidity indicators evolution
FRANCODEX SANTE ANIMALE

Sector positioning

Liquidity ratio
353.28 2024
2019
2023
2024
Q1: 132.74
Med: 202.27
Q3: 325.9
Excellent +47 pts over 3 years

In 2024, the liquidity ratio of FRANCODEX SANTE ANIMALE (353.28) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
16.57x 2019
2019
Q1: 0.0x
Med: 0.14x
Q3: 4.04x
Excellent

In 2019, the interest coverage of FRANCODEX SANTE ANIMALE (16.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
FRANCODEX SANTE ANIMALE

Positioning of FRANCODEX SANTE ANIMALE in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of FRANCODEX SANTE ANIMALE is estimated at 731 763 € (range 278 514€ - 2 672 307€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
124 transactions
278k€ 731k€ 2672k€
731 763 € Range: 278 514€ - 2 672 307€
NAF 5 all-time

Valuation method used

Net Income Multiple
890 748 € × 0.8x = 731 763 €
Range: 278 514€ - 2 672 307€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare FRANCODEX SANTE ANIMALE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about FRANCODEX SANTE ANIMALE

What is the revenue of FRANCODEX SANTE ANIMALE ?

The revenue of FRANCODEX SANTE ANIMALE in 2019 is 8.0 M€.

Is FRANCODEX SANTE ANIMALE profitable?

Yes, FRANCODEX SANTE ANIMALE generated a net profit of 891 k€ in 2024.

Where is the headquarters of FRANCODEX SANTE ANIMALE ?

The headquarters of FRANCODEX SANTE ANIMALE is located in SAINTES (17100), in the department Charente-Maritime.

Where to find the tax return of FRANCODEX SANTE ANIMALE ?

The tax return of FRANCODEX SANTE ANIMALE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does FRANCODEX SANTE ANIMALE operate?

FRANCODEX SANTE ANIMALE operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.